Global pharmaceutical filtration market value of USD 20,190.1 million by 2020
Analysis, trends and opportunities report 2016–2020 — key vendors: General Electric, Pall Corporation, 3M.
Research and Markets has added "Pharmaceutical Filtration Market by Product (Membrane Filters, Single-use systems), Techniques (Ultrafiltration, Cross Flow Filtration), Applications, Scale of Operations, Geography (North America, Europe) — Global Forecast to 2020" report to their offering.
This comprehensive report predicts that the global market will be worth USD 20,190.1 million by 2020. The major drivers for the market include the growth of biopharmaceutical industry, advancement in nanofiber technology, rapid expansion in generic drug production, increasing incidences of airborne disease, and strong biologics product pipeline. The emerging nations will provide new growth opportunities for this market. The report provides a granular understanding of the market for pharmaceutical filtration. This report segments the global market on the basis of product, technique, application, scale of operation, and geographies. The product segments included in this report are membrane filters, prefilters and depth media, cartridges and capsules, single-use systems, filter holders, filtration accessories.
The major players in this market include Merck & Co., Inc. (US), General Electric Company (US), Pall Corporation (US), Parker Hannifin Corporation (US), Sartorius Stedim Biotech Group (France), and 3M (US), Eaton Corporation Plc (Ireland), Amazon Filters Ltd (United Kingdom), Graver Technologies, LLC. (US), and Meissner Filtration Products, Inc. (US).
Key Topics Covered:Related News
-
News US BIOSECURE Act passed by US House of Representatives
The controversial act, which has already impacted several foreign companies operating in the US, was passed by the House of Representatives on September 9, 2024. It is now headed for the US Senate before it can be signed into law by President Joe Biden... -
News Pharma Supply Chain People Moves
The latest appointments, promotions, and structural changes across the pharmaceutical supply chain. -
News Drug prices agreed upon as part of the US Inflation Reduction Act
The Inflation Reduction Act brought into constitution by the Biden administation in 2022, which proposed a drug price negotiation between the government and pharmaceutical companies, has reached it's first agreement. -
.png)
News BIOSECURE Act continues to loom over Chinese pharma manufacturers
With the US BIOSECURE Act on its way to passing into legislation, Chinese companies are facing declining revenues within the first half of 2024 as US pharmaceutical and healthcare companies pull their businesses from the country. -
.png)
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
.png)
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
.png)
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance